Advertisement




Megadeth's Dave Mustaine Diagnosed With Cancer 2019 In Review

William Lee | 12-28-2019

Megadeth's Dave Mustaine Diagnosed With Cancer was a top 19 story of June 2019: Megadeth frontman Dave Mustaine shared the sad news with fans that he has been diagnosed with throat cancer and the band has been forced to cancel most of their live dates for the year as he seeks treatment.

Mustaine broke the news to fans on Instagram with the following message, "I've been diagnosed with throat cancer. It's clearly something to be respected and faced head on - but I've faced obstacles before. I'm working closely with my doctors, and we've mapped out a treatment plan which they feel has a 90% success rate. Treatment has already begun.

"Unfortunately, this requires that we cancel most shows this year. The 2019 Megacruise will happen, and the band will be a part of it in some form. All up to date information will be at megadeth.com as we get it. Megadeth will be back on the road ASAP.

"Meanwhile, Kiko, David, Dirk and I are in the studio, working on the follow up to Dystopia - which I can't wait for everyone to hear.I'm so thankful for my whole team - family, doctors, band members, trainers, and more.

"I'll keep everyone posted."


Advertisement




Related Stories

Megadeth Star Highlights The 1st Metal Christmas Rendition Of 'Carol Of The Bells'

David Ellefson Rocks Judas Priest Classic And Reveals Bass Warrior Tour Dates

Megadeth, Arizona Resurrected For 'Youthanasia' 30th Anniversary

Singled Out: Cathy Rankin's Now You've Gone' (Tribute To Neil Peart)

Cathy Rankin Recruits Megadeth and Alice Cooper Stars For Neil Peart Tribute

News Reports
Day in Rock: Sammy Hagar Reveals Classic Song That Alex Van Halen Rejected- Amen's Casey Chaos Had Project With Roy Mayorga- more

Becoming Led Zeppelin Hitting Movie Theaters On Valentine's Day- Sammy Hagar Shares Video For Van Halen Classic From The Best Of All Worlds Tour- more


Contact Us - Privacy

Copyright 2023 Iconoclast Entertainment Group All rights reserved.